HomeMEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.
This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.
Glasgow Company’s Lifesaving Technology for Less Invasive Heart Surgery Making International Mark
A Glasgow-based company focused on less invasive heart surgery treatment of structural heart disease is making its mark on the international stage.
Kidd & Company, LLC Exits NextPhase Medical Devices, LLC
Kidd & Company advises NextPhase is a class II and III medical device contract manufacturer of complex electromechanical devices, active implantable devices and single use disposables in North America. It provides design and engineering, manufacturing and assembly, quality and regulatory, and supply chain and logistics management services enabling its customers to bring low-to-medium volume complex medical devices to market.
The MiniMed™ 780G System with Meal Detection™ Technology* Now Available to Medicare Beneficiaries
The MiniMed™ 780G system delivers automatic adjustments and corrections† to sugar levels every 5 minutes§ to provide coverage for when users occasionally forget to bolus or underestimate the number of carbs in their meal. It features the lowest target setting (as low as 100 mg/dL) in any automated insulin pump on the market§ to more closely mirror the average glucose of someone not living with diabetes.
CMS Establishes HCPCS code for Ultromics EchoGo ® Heart Failure, Accelerating Access to Precision HFpEF Detection
Ultromics EchoGo ® Heart Failure is the first US Food and Drug Administration (FDA) cleared platform for detecting Heart Failure with Preserved Ejection Fraction (HFpEF), using a single view of an echocardiogram. The platform has the potential to catch disease earlier and get more patients on the pathway to treatment.
CPR Therapeutics Inc. Receives Three Patents In One Week For Innovations In Cardiopulmonary Resuscitation Technology
Norman Paradis MD, CPR Therapeutics Founder and CEO stated: “Receiving all three patents in one week is a wonderful coincidence that highlights the breadth of our innovation. We already knew that our existing patent portfolio was strong and provided a sound foundation for our future commercial efforts. Now it is even stronger. I believe any one of these patents could justifiably be called a breakthrough invention in and of itself.”
Medical Syringe: The Alternatives With High-Quality Materials
Medical syringes are indispensable tools in healthcare settings, facilitating the safe and precise administration of medications, vaccines, and other substances. Traditionally made from glass...
Medovate Signs First Distributor Agreement for its Pioneering SAFIRA® Technology in the Veterinary Field with 20/20 Imaging in the USA
Bob Salzman, President 20/20 Imaging said: “This is a ground-breaking new technology for safer regional anesthesia and is unique in making it a one person procedure and reducing reliance on subjective 'injection pressure feel'. 20/20 Imaging are proud to be the first appointed distributor to be bringing its unique benefits to the veterinary market and we look forward to making this exciting technology available to veterinary professionals across America alongside our leading range of ultrasound solutions to enable them to deliver the best care for their patients.”
Relievant Medsystems Announces Favorable Coverage Policy from Cigna Healthcare for the Intracept Procedure
“This positive coverage determination from Cigna Healthcare, one of the country’s leading health benefit providers, is vastly impactful in increasing patient and physician access to our proven treatment for vertebrogenic pain,” said Tyler Binney, President and CEO of Relievant Medsystems.
NIOX® Group Celebrates 25 Years of Innovation in FeNO Testing for Asthma
Since its foundation, the company has worked to help improve asthma care with its ground-breaking FeNO testing devices. With almost 50 million tests performed worldwide, NIOX® continues to lead the development of FeNO for patient care.
